GuruTrack
INCY

INCY

INCYTE CORP

Data as of 2026 Q2 (06-30) · 13F snapshot

Summary
INCYTE CORP (INCY) is held as common stock by 9 tracked hedge-fund managers, with a combined reported value of ~$5.40B; the largest are Baker Bros. Advisors, Dodge & Cox, Renaissance Technologies. 3 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 4 added, 4 trimmed, 1 closed. 7 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · HighThis quarter · Mixed
Common-stock holders93 also report options
Congress trades7
Price$124.82vs quarter-end+10.11%
Sectors1
This quarter's moves
New0
Added4
Trimmed / sold5
Top holderBaker Bros. Advisors

Common-stock positions

PUT and CALL disclosures are excluded from these holder counts and values.

Baker Bros. AdvisorsHold
Value $3.49B17.5% of portfolio30,762,3302026 Q2

PUT / CALL disclosures

Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.

Ken GriffinCALL—
Value $11.61M— of portfolio102,4002026 Q2
Izzy EnglanderCALL—
Value $11.38M— of portfolio100,4002026 Q2
Ken GriffinPUT—
Value $5.91M— of portfolio52,1002026 Q2
Paul Tudor JonesCALL—
Value $3.09M— of portfolio27,3002026 Q2

Insider Trading

Officers · directors · Form 4
Open-market purchases and sales (P/S)10

  • Pablo J Cagnoni

    President, Global Head of R&D

    Sell$1.11M
    9,233 @ $120.50Traded 2026-09-15Filed 2026-09-17

  • Pablo J Cagnoni

    President, Global Head of R&D

    Sell$1.69M
    13,985 @ $120.49Traded 2026-09-15Filed 2026-09-17

  • Pablo J Cagnoni

    President, Global Head of R&D

    Sell$1.36M
    10,801 @ $125.56Traded 2026-08-19Filed 2026-08-20

  • Pablo J Cagnoni

    President, Global Head of R&D

    Sell$1.30M
    10,803 @ $120.04Traded 2026-08-12Filed 2026-08-14

  • Patrick A Mayes

    EVP & Chief Scientific Officer

    Sell$273.6K
    2,207 @ $123.99Traded 2026-08-05Filed 2026-08-07

  • Pablo J Cagnoni

    President, Global Head of R&D

    Sell$1.31M
    10,640 @ $122.69Traded 2026-08-05Filed 2026-08-07

  • Patrick A Mayes

    EVP & Chief Scientific Officer

    Sell$196.0K
    1,642 @ $119.38Traded 2026-07-31Filed 2026-08-04

  • Patrick A Mayes

    EVP & Chief Scientific Officer

    Sell$196.4K
    1,643 @ $119.51Traded 2026-07-31Filed 2026-08-04

  • Patrick A Mayes

    EVP & Chief Scientific Officer

    Sell$729.2K
    6,055 @ $120.43Traded 2026-07-31Filed 2026-08-04

  • Patrick A Mayes

    EVP & Chief Scientific Officer

    Sell$10.4K
    85 @ $122.19Traded 2026-07-31Filed 2026-08-04

Insider transactions are public SEC Form 4 disclosures (company officers, directors, 10% owners), for research only — not investment advice.

Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.